KL
ABBV icon

KWMG LLC’s AbbVie ABBV Stock Holding History

KWMG LLC’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$369K Buy
1,409
+12
+0.9% +$3.08K 0.03% 129
2026
Q2 		$352K Hold
1,397
– – 0.03% 130
2026
Q1 		$304K Sell
1,397
-15
-1% -$3.33K 0.03% 132
2025
Q4 		$323K Buy
1,412
+40
+3% +$9.11K 0.03% 133
2025
Q3 		$318K Hold
1,372
– – 0.03% 132
2025
Q2 		$255K Hold
1,372
– – 0.02% 139
2025
Q1 		$287K Buy
1,372
+128
+10% +$24.9K 0.03% 132
2024
Q4 		$221K Hold
1,244
– – 0.02% 136
2024
Q3 		$246K Hold
1,244
– – 0.02% 129
2024
Q2 		$213K Hold
1,244
– – 0.02% 130
2024
Q1 		$227K Buy
+1,244
New +$214K 0.02% 126
2023
Q2 		– Sell
-1,365
Closed -$218K – 136
2023
Q1 		$218K Buy
1,365
+97
+8% +$14.8K 0.03% 136
2022
Q4 		$205K Buy
+1,268
New +$194K 0.03% 136
2019
Q2 		– Sell
-976
Closed -$79K – 115
2019
Q1 		$79K Sell
976
-77
-7% -$6.3K 0.02% 149
2018
Q4 		$97K Sell
1,053
-87
-8% -$7.65K 0.03% 127
2018
Q3 		$108K Sell
1,140
-109
-9% -$10.3K 0.03% 123
2018
Q2 		$116K Sell
1,249
-19,686
-94% -$1.92M 0.03% 118
2018
Q1 		$1.98M Sell
20,935
-5,990
-22% -$658K 0.58% 54
2017
Q4 		$2.6M Buy
26,925
+404
+2% +$38.1K 0.78% 26
2017
Q3 		$2.36M Buy
26,521
+1,561
+6% +$119K 0.78% 29
2017
Q2 		$1.81M Buy
24,960
+1,797
+8% +$121K 0.64% 39
2017
Q1 		$1.51M Buy
23,163
+3,811
+20% +$240K 0.58% 58
2016
Q4 		$1.21M Buy
19,352
+4,497
+30% +$274K 0.53% 59
2016
Q3 		$937K Buy
14,855
+1,611
+12% +$104K 0.46% 66
2016
Q2 		$820K Buy
+13,244
New +$807K 0.44% 68

Other funds holding ABBV

HCM
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

KWMG LLC's ABBV Position: Q3 2026 in Review

KWMG LLC increased its AbbVie (ABBV) stake by 0.86% in Q3 2026, buying an estimated $3.08K and bringing the position to 1,409 shares worth $369K. The position accounts for 0.03% of the portfolio, ranked #129.

KWMG LLC first reported a position in ABBV in Q2 2016 and has held it in 25 quarters since. The position peaked at $2.6M in Q4 2017. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • KWMG LLC held 1,409 shares of AbbVie worth $369K as of Q3 2026.
  • KWMG LLC bought 12 AbbVie shares in Q3 2026, an estimated $3.08K.
  • AbbVie made up 0.03% of KWMG LLC's portfolio in Q3 2026, its #129 holding.
  • KWMG LLC first reported a position in AbbVie in Q2 2016 and has held it in 25 quarters since.
  • KWMG LLC's AbbVie position peaked at $2.6M in Q4 2017.
  • 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on KWMG LLC's 13F filing for Q3 2026, filed 7 Oct 2026.